A ten-year prospective survey of neuroleptic malignant syndrome (NMS) was p
erformed in a major psychiatric hospital (1,510 beds) in Moscow. All inpati
ents who developed a persistent and severe extrapyramidal rigidity accompan
ied by fever after exposure to neuroleptic medication were screened for NMS
. The diagnosis of NMS was established according to Levenson's criteria and
at a later stage all NMS Gases were reevaluated using the DSM-IV research
criteria. Data on age, gender and psychiatric diagnoses were analyzed. Of t
he 78,708 inpatients treated with neuroleptic agents, 19 separate patients
had an episode of NMS, for a frequency of 0.02%. Mortality rate was 10.5% (
2/19 patients). Of the three potential risk factors studied, only young age
(less than or equal to 25 years) was significantly associated with an incr
eased frequency of NMS (P < 0.01). The low rate of NMS found here compared
to studies in other countries may be due to the stringent demands for NMS d
iagnosis. More large-scale prospective studies including detailed clinical
and laboratory data are needed to clarify these differences and their impac
t on the prevalence and risk factors of NMS. (C) 2000 Editions scientifique
s et medicales.